Transfusion and Apheresis Science
Volume 41, Issue 3 , Pages 209-216, December 2009

Extracorporeal photo-apheresis for the treatment of steroid-resistant graft versus host disease☆☆☆

  • Kristin Baird

      Affiliations

    • Corresponding Author InformationCorresponding author. Address: Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 1W-3750, 9000 Rockville Pike, Bethesda, MD 20892-1104, USA. Tel.: +001 301 496 4256; fax: +001 301 451 7010.
    • ,
  • Alan S. Wayne

Pediatric Oncology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA

Abstract 

Acute and chronic graft versus host disease are frequent and potentially severe complications of allogeneic hematopoietic stem cell transplantation and are among the leading causes of non-relapse transplant-related mortality. For patients with steroid refractory disease, prognosis is particularly poor and although a variety of treatment options are available, responses are commonly transient and the side effects often intolerable. Since it was first introduced for the treatment of cutaneous T-cell lymphoma, extracorporeal photo-apheresis has been utilized as an immunomodulatory therapy for certain autoimmune diseases and solid organ transplant rejection. Recently, extracorporeal photo-apheresis has become a promising alternative for patients with graft versus host disease with disabling or potentially lethal complications. Here we review the experience of extracorporeal photo-apheresis for the treatment of steroid refractory acute and chronic graft versus host disease based on the current literature.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

☆ This work was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.

☆☆ The authors are employees of the United States Government, and, as such, this work was done in that capacity. The views expressed do not necessarily represent the views of the National Institutes of Health or the United States Government.

PII: S1473-0502(09)00146-3

doi:10.1016/j.transci.2009.09.007

Transfusion and Apheresis Science
Volume 41, Issue 3 , Pages 209-216, December 2009

Article Tools